ACO Name and Location

Privia Quality Network, LLC
950 N Glebe Rd
Suite 700
Arlington, VA 22203

ACO Primary Contact

Deepa Achutuni
Phone: 571-366-8850
Email: deepa.achutuni@priviahealth.com

Organizational Information

ACO Participants:

ACO Participants ACO Participant in Joint Venture
Accessible Physician Home Care, LLC N
Allergy And Asthma Clinic Of Maryland N
Anchor Healthcare PLC N
Anju Verma, M.D., PC N
Bay West Endocrinology Associates PA N
Best Health Services PC N
Betsy Vasquez N
Capital Heartcare Center PC N
Carol C. Jagdeo, M.D., LLC N
Central Virginia Family Physicians, Inc. N
Chickahominy Family Practice Inc N
Clifton Care LLC N
Comprehensive Neurology And Sleep Medicine, P.A. N
Denise Chevalier Hamilton N
Felice Physical Therapy N
Forsyth Medical Group, LLC N
GP Therapy, LLC N
Greenway Endocrinology, P.A. N
IPS Of Winchester LLC N
Lawrence Miller N
Matthew S. Kaatz, M.D., P.C. N
Metro Orthopedics & Sports Therapy N
Mount Vernon Internal Medicine N
Neda Hashemi, M.D., PC N
Nephrology & Hypertension Of Virginia, PLLC N
Newbridge Spine And Pain Center LLC N
Next Journey Orthopaedics PLLC N
Ortho OIC Orthopaedic Immediate Care LLC N
Prime Medical Care, LLC N
Prismamed Services LLC N
Privia Medical Group LLC N
Providence Family & Sports Medicine Inc N
Ronald W. Atwood, M.D., PC N
Sherman Kahan, M.D., P.A. N
Virginia Head And Neck Surgeons PC N
Virginia Womens Center INC N
William Linthicum N

ACO Governing Body:

Member First Name Member Last Name Member Title/Position Member’s Voting Power – Expressed as a percentage Membership Type ACO Participant TIN Legal Business Name/DBA, if Applicable
Keith Berkle Chairman 10% ACO Participant Privia Medical Group LLC
Jane Belford Director 10% Beneficiary Representative N/A
Stephanie Carter Director 10% ACO Participant Privia Medical Group LLC
Corey Perdue Director 10% Other N/A
Habib Chotani Director 10% ACO Participant Privia Medical Group LLC
Thomas Eppes Director 10% ACO Participant Privia Medical Group LLC
Ann Marie Gordon Director 10% ACO Participant Privia Medical Group LLC
Caitlin Zaner Director 10% ACO Participant Privia Medical Group LLC
David West Director 10% ACO Participant Privia Medical Group LLC
Linda Powers Director 10% ACO Participant Privia Medical Group LLC

 

Key ACO Clinical and Administrative Leadership:

ACO Executive: Eric Beyer
Medical Director: Fred Taweel
Compliance Officer: Stephanie Clark
Quality Assurance/Improvement Officer: David West

Associated Committees and Committee Leadership:

Committee Name Committee Leader Name and Position
Clinical IT Committee Jarret Dodd, Chair
Clinical Performance Committee David West, Chair
Compliance Committee Caroline Huang, Chair
Credentialing Committee Habib Chotani, Chair
Finance Committee Jeffrey Bernstein, Chair

Types of ACO participants, or combinations of participants, that formed the ACO:

  • ACO professionals in a group practice arrangements
  • Networks of individual practices of ACO professionals

Shared Savings and Losses

Amount of Shared Savings/Losses

  • Third Agreement Period
    • Performance Year 2023: $51,566,511
    • Performance Year 2022: $44,130,899
    • Performance Year 2021: $41,642,012
    • Performance Year 2020: $42,266,717
  • Second Agreement Period
    • Performance Year 2019: $16,998,165
    • Performance Year 2018: $20,066,830
    • Performance Year 2017: $18,079,932
  • First Agreement Period
    • Performance Year 2016: $0
    • Performance Year 2015: $6,156,225
    • Performance Year 2014: $2,793,592

Shared Savings Distribution

  • Third Agreement Period
    • Performance Year 2023
      • Proportion invested in infrastructure: 30%
      • Proportion invested in redesigned care processes/resources: 10%
      • Proportion of distribution to ACO participants: 60%
    • Performance Year 2022
      • Proportion invested in infrastructure: 30%
      • Proportion invested in redesigned care processes/resources: 10%
      • Proportion of distribution to ACO participants: 60%
    • Performance Year 2021
      • Proportion invested in infrastructure: 30%
      • Proportion invested in redesigned care processes/resources: 10%
      • Proportion of distribution to ACO participants: 60%
    • Performance Year 2020
      • Proportion invested in infrastructure: 30%
      • Proportion invested in redesigned care processes/resources: 10%
      • Proportion of distribution to ACO participants: 60%
  • Second Agreement Period
    • Performance Year 2019
      • Proportion invested in infrastructure: 30%
      • Proportion invested in redesigned care processes/resources: 10%
      • Proportion of distribution to ACO participants: 60%
    • Performance Year 2018
      • Proportion invested in infrastructure: 30%
      • Proportion invested in redesigned care processes/resources: 10%
      • Proportion of distribution to ACO participants: 60%
    • Performance Year 2017
      • Proportion invested in infrastructure: 30%
      • Proportion invested in redesigned care processes/resources: 10%
      • Proportion of distribution to ACO participants: 60%
  • First Agreement Period
    • Performance Year 2016
      • Proportion invested in infrastructure: N/A
      • Proportion invested in redesigned care processes/resources: N/A
      • Proportion of distribution to ACO participants: N/A
    • Performance Year 2015
      • Proportion invested in infrastructure: 30%
      • Proportion invested in redesigned care processes/resources: 10%
      • Proportion of distribution to ACO participants: 60%
    • Performance Year 2014
      • Proportion invested in infrastructure: 30%
      • Proportion invested in redesigned care processes/resources: 10%
      • Proportion of distribution to ACO participants: 60%

Quality Performance Results

2023 Quality Performance Results:

Quality Performance Results are based on CMS Web Interface Measure Set

Measure # Measure Name Collection Type Reported Performance Rate Current Year Mean Performance Rate (SSP ACO’s)
Measure # 001 Diabetes: Hemoglobin A1c (HbA1c) Poor Control (>9%) CMS Web Interface 9.02 9.84
Measure # 134 Preventative Care and Screening: Screening for Depression and Follow-up Plan CMS Web Interface 83.13 80.97
Measure # 236 Controlling High Blood Pressure CMS Web Interface 80.72 77.80
Measure # 318 Falls: Screening for Future Fall Risk CMS Web Interface 93.88 89.42
Measure # 110 Preventative Care and Screening: Influenza Immunization CMS Web Interface 78.28 70.76
Measure # 226 Preventative Care and Screening: Tobacco Use: Screening and Cessation Intervention CMS Web Interface 81.82 79.29
Measure # 113 Colorectal Cancer Screening CMS Web Interface 82.75 77.14
Measure # 112 Breast Cancer Screening CMS Web Interface 80.08 80.36
Measure # 438 Statin Therapy for the Prevention and Treatment of Cardiovascular Disease CMS Web Interface 83.33 87.05
Measure # 370 Depression Remission at Twelve Months CMS Web Interface 35.42 16.58
Measure # 321 CAHPS for MIPS CMS Web Interface 6.16 6.25
Measure # 479 Hospital-Wide, 30-Day, All-Cause Unplanned Readmission (HWR) Rate for MIPS Groups CMS Web Interface 0.1428 0.1553
Measure # 484 Clinician and Clinician Group Risk-standardized Hospital Admission Rates for Patients with Multiple Chronic Conditions CMS Web Interface 46.03 35.39
CAHPS-1 Getting Timely Care, Appointments, and Information CAHPS for MIPS Survey 82.39 83.68
CAHPS-2 How Well Providers Communicate CAHPS for MIPS Survey 93.57 93.69
CAHPS-3 Patient’s Rating of Provider CAHPS for MIPS Survey 92.17 92.14
CAHPS-4 Access to Specialists CAHPS for MIPS Survey 73.95 75.97
CAHPS-5 Health Promotion and Education CAHPS for MIPS Survey 68.07 63.93
CAHPS-6 Shared Decision Making CAHPS for MIPS Survey 61.58 61.60
CAHPS-7 Health Status and Functional Status CAHPS for MIPS Survey 77.03 74.12
CAHPS-8 Care Coordination CAHPS for MIPS Survey 86.33 85.77
CAHPS-9 Courteous and Helpful Office Staff CAHPS for MIPS Survey 92.38 92.31
CAHPS-11 Stewardship of Patient Resources CAHPS for MIPS Survey 26.97 26.69

For Previous Years’ Financial and Quality Performance Results, Please Visit data.cms.gov

Payment Rule Waivers

  • Skilled Nursing Facility (SNF) 3-Day Rule Waiver
    • Our ACO does use the SNF 3-Day Rule Waiver, pursuant to 42 CFR § 425.612.